慢性阻塞性肺病与败血症患者28天死亡率之间的关联:基于MIMIC-III数据库的回顾性研究
Yubiao Chen1,2,3, Lifei Lu2,3,4, Xicong Li5
1Department of Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
BMC pulmonary medicine
|November 10, 2023
概括
慢性阻塞性肺病 (COPD) 是败血症患者28天死亡的独立风险因素. 患有COPD的个人在败血症治疗期间需要额外的护理.
科学领域:
- 关键护理医学 关键护理医学
- 肺部病理学 肺部病理学
- 流行病学 流行病学
背景情况:
- 败血症是重症患者的主要死亡原因.
- 慢性阻塞性肺病 (COPD) 是败血症中常见的并发症.
- 之前,COPD对败血症预后的影响尚不清楚.
研究的目的:
- 评估COPD对败血症患者预后的影响.
- 使用了密集护理医疗信息中心 (MIMIC-III) 数据库.
主要方法:
- 使用MIMIC-III数据库 (v1.4) 进行了回顾性研究.
- 包括符合败血症3标准的败血症患者 (2008-2012).
- 使用ICD-9代码识别了COPD;通过Kaplan-Meier和Cox模型分析了28天的全因死亡率.
主要成果:
- 包括6257名败血症患者 (955名COPD患者).
- 慢性肺炎患者年龄较大,SAPSII分数较高,使用机械通风器的比例较高.
- 慢性肺炎患者的28天全因死亡率明显较高 (23.6%与16.4%相比).
结论:
- 慢性肺炎是败血症28天死亡率的一个独立风险因素.
- 患有COPD的败血症患者需要加强临床管理和监测.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
01:30Pneumonia I: Introduction
247
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
247
01:30Pneumonia III: Complications and Assessment
241
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
241
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:28Pneumonia IV: Management
338
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
338